In the News
Acquired Resistance and Clonal Evolution in Melanoma During BRAF Inhibitor Therapy
BRAF inhibitors elicit rapid antitumor responses in the majority of patients with BRAFV600-mutant melanoma, but acquired drug resistance is almost universal. We sought to identify the core resistance pathways and the extent of tumor heterogeneity during disease progression. Click here to read on. Link to the Complete Story.
For Cosmetic Appointments Call (310) 206-SKIN (7546)
The faculty and staff of UCLA Dermatology strive to achieve excellence in patient care, education and research. Our goals are:
- To provide outstanding individualized diagnosis and treatment of skin disease.
- To educate the next generation of physicians and scientists to become leaders in medical dermatology, cosmetic dermatology, dermatologic surgery, dermatopathology and investigative dermatology.
- To develop new and better strategies to diagnose and treat skin disease through innovative research.
Our faculty, residents, students and staff are pleased and committed to serve you.